Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Signal Transduction and Targeted Therapy
|
April 8, 2025
Tripeptide DT-109 (Gly-Gly-Leu) attenuates atherosclerosis and vascular calcification in nonhuman primates
Linying Jia, Pengxiang Qu, Yang Zhao, et al.
Cell Metabolism
|
April 11, 2023
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Pengxiang Qu, Oren Rom, Ke Li, et al.
The Journal of Clinical Investigation
|
May 12, 2026
Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109
Pengxiang Qu, Shusi Ding, Yanru Zhang, et al.
Nature Immunology
|
May 22, 2026
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines
Kautilya K Jena, Pengxiang Qu, Lauren Baracco, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Signal Transduction and Targeted Therapy
|
April 8, 2025
Tripeptide DT-109 (Gly-Gly-Leu) attenuates atherosclerosis and vascular calcification in nonhuman primates
Linying Jia, Pengxiang Qu, Yang Zhao, et al.
Cell Metabolism
|
April 11, 2023
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Pengxiang Qu, Oren Rom, Ke Li, et al.
The Journal of Clinical Investigation
|
May 12, 2026
Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109
Pengxiang Qu, Shusi Ding, Yanru Zhang, et al.
Nature Immunology
|
May 22, 2026
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines
Kautilya K Jena, Pengxiang Qu, Lauren Baracco, et al.
Page
of 4